# Mechanisms of Refractory Hypertension (Carvedilol)

> **NCT02357004** · NA · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Hypertensive

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Chlorthalidone

## Key facts

- **NCT ID:** NCT02357004
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in priority of interventional protocols
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357004, "Mechanisms of Refractory Hypertension (Carvedilol)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02357004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*